Kymera Therapeutics, Inc.
KYMR
Revenue
7.39M
▲3.65M▲97.65%
3 Months ChangeAssets
978.04M
▼-56.81M▼-5.49%
3 Months ChangeLiabilities
142.42M
▲504.00k▲0.3551%
3 Months ChangeFree Cash Flow
-46.99M
▲984.00k▲2.05%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0000950170-24-119249
2024-10-31
Form 8-K
ID: 0000950170-24-119245
2024-08-20
Form 8-K
ID: 0001193125-24-203755
2024-08-07
Form 10-Q
ID: 0000950170-24-092275
2024-08-07
Form 8-K
ID: 0000950170-24-092272
2024-07-08
Form 8-K
ID: 0001193125-24-176312
2024-06-20
Form 8-K
ID: 0001193125-24-164550
2024-05-02
Form 10-Q
ID: 0000950170-24-051567
2024-05-02
Form 8-K
ID: 0000950170-24-051566
2024-04-01
Form 8-K
ID: 0001193125-24-082641